Table 2.
Currently conducted H. pylori-gastric cancer intervention trials with cancer endpoints
Name | Country | Target group | Age group | Sample size | Main endpoints |
SCISC | China | Population | 30-65 | 2400 | Gastric cancer |
NCI | China | Population | 35-69 | 3400 | Gastric cancer , dysplasia |
JITHP | Japan | Population | 20-59 | 5000 | Gastric cancer |
BUPA | U.K. | Population | 35-69 | 56000 | Gastric cancer |
PRISMA Germany | Male subjects | 55-65 | 3000 | Gastric cancer | |
Austria | with | dysplasia,adenoma | |||
Tchech | Corpus | ||||
Republic | dominant | ||||
gastritis |